BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 5290549)

  • 1. Comparison of the bronchodilator and cardiovascular actions of salbutamol, isoprenaline and orciprenaline in guinea-pigs and dogs.
    Daly MJ; Farmer JB; Levy GP
    Br J Pharmacol; 1971 Nov; 43(3):624-38. PubMed ID: 5290549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of isoprenaline, orciprenaline, salbutamol and isoetharine on the cardiovascular system of anaesthetized dogs.
    Ekue JM; Shanks RG; Zaidi SA
    Br J Pharmacol; 1971 Sep; 43(1):23-31. PubMed ID: 5136459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of a new bronchodilator, S-1540 (Bitolterol) and S-1541 on the tracheo-bronchial and cardiovascular system].
    Ono N; Kushiku K; Morishita H; Nakagami K; Nakahara T
    Nihon Yakurigaku Zasshi; 1975 Oct; 71(7):739-52. PubMed ID: 1240071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the pharmacology of salbutamol with that of isoprenaline, orciprenaline and trimetoquinol.
    Brittain RT
    Postgrad Med J; 1971 Mar; 47():Suppl:11-6. PubMed ID: 5572509
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacodynamics of a new selective beta2-adrenergic bronchodilator 3-(4-methoxybenzylamino)-4-hydroxy-alpha-(tert. butylaminomethyl)-benzyl-alcohol, HCl (QH25).
    Larsen JJ; Hermansen K
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40(1):42-64. PubMed ID: 576362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. I: Bronchodilating effect.
    Murai T; Maejima T; Sanai K; Osada E
    Arzneimittelforschung; 1984; 34(11A):1633-40. PubMed ID: 6152156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salbutamol: a new, selective beta-adrenoceptive receptor stimulant.
    Cullum VA; Farmer JB; Jack D; Levy GP
    Br J Pharmacol; 1969 Jan; 35(1):141-51. PubMed ID: 5762037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilator and cardiac effects of isoprenaline, orciprenaline, and salbutamol aerosols in asthma.
    Milner AD; Ingram D
    Arch Dis Child; 1971 Aug; 46(248):502-7. PubMed ID: 5565461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bronchodilator and cardiac stimulant effects of Thll65a, salbutamol and isoproterenol.
    Giles RE; Williams JC; Finkel MP
    J Pharmacol Exp Ther; 1973 Sep; 186(3):472-81. PubMed ID: 4147005
    [No Abstract]   [Full Text] [Related]  

  • 10. Salbutamol and orciprenaline-induced changes in myocardial function.
    Nayler WG; McInnes I
    Cardiovasc Res; 1972 Nov; 6(6):725-33. PubMed ID: 4656479
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the cardiovascular actions of AQ 110 with those of isoprenaline and salbutamol.
    Fogelman F; Grundy HF
    Br J Pharmacol; 1970 Feb; 38(2):416-32. PubMed ID: 4392103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency and selectivity in vitro of compounds related to isoprenaline and orciprenaline on beta-adrenoceptors in the guinea-pig.
    O'Donnell SR; Wanstall JC
    Br J Pharmacol; 1974 Nov; 52(3):407-17. PubMed ID: 4458848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some observations on the pharmacological effects of salbutamol, with particular reference to the cardiovascular system.
    Nayler WG
    Postgrad Med J; 1971 Mar; 47():Suppl:16-21. PubMed ID: 5572512
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the beta-adrenoceptor stimulant properties of salbutamol, orciprenaline and soterenol with those of isoprenaline.
    Farmer JB; Levy GP; Marshall RJ
    J Pharm Pharmacol; 1970 Dec; 22(12):945-7. PubMed ID: 4395522
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiovascular action of Salbutamol].
    Oshima T; Koike H; Nakayama K; Takagi H
    Nihon Yakurigaku Zasshi; 1972 Jan; 68(1):73-85. PubMed ID: 5065041
    [No Abstract]   [Full Text] [Related]  

  • 16. The selectivity of beta-adrenoceptor antagonists on cardiovascular and bronchodilator responses to isoprenaline in the anaesthetized dog.
    Daly MJ; Flook JJ; Levy GP
    Br J Pharmacol; 1975 Feb; 53(2):173-81. PubMed ID: 238697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiorespiratory effects of intravenous isoprenaline and salbutamol in dogs.
    Loh L; Seed RF; Sykes MK
    Br J Pharmacol; 1971 Mar; 41(3):445-53. PubMed ID: 5576253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchodilating and cardiovascular effects of intraduodenally and orally administered clenbuterol in dogs.
    Kato H; Nakayama K; Takata Y; Kurihara J; Sakai T; Iwata K; Yamamoto I
    Arzneimittelforschung; 1985; 35(7):1037-41. PubMed ID: 4052137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative evaluation of the bronchodilator effects and cardiovascular effects of 3 beta adrenergic stimulants in bronchial asthma--comparison of isoproterenol, metaproterenol and salbutamol].
    Matsumoto S; Tanaka Y; Wagatsuma Y; Miura R; Umezu A
    Arerugi; 1971 Aug; 20(8):599-609. PubMed ID: 4398383
    [No Abstract]   [Full Text] [Related]  

  • 20. The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.
    Marlin GE; Turner P
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):158-69. PubMed ID: 240780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.